This study looked at adults who were hospitalized with confirmed COVID-19. It compared how severe their illness was during two different time periods: one before the Delta variant became the main virus strain, and one when the Delta variant was most common. The goal was to see if disease severity changed between these periods. The research was conducted across 14 states as part of the COVID-NET surveillance network. The study did not report the number of patients included, the specific severity measures used, or the actual results of the comparison. No information was provided about patient safety concerns or adverse events during hospitalization. The main reason to be careful with these findings is that this was an observational study. This type of study can show patterns or links between time periods and disease severity, but it cannot prove that the Delta variant directly caused any change. Many other factors could have been different between the two time periods, like vaccination rates, hospital protocols, or patient characteristics. Readers should know that this report does not provide clear answers about whether the Delta variant led to more severe COVID-19 in hospitalized adults. The study summary is incomplete, and the actual findings were not reported. More complete research would be needed to understand any potential connection.
Study compares COVID-19 severity in hospitalized adults before and during Delta variant period
Photo by Zoshua Colah / Unsplash
What this means for you:
An incomplete study compared COVID-19 severity before and during Delta, but reported no results. More information is needed. More on COVID-19
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders Clozapine users faced higher risk of severe COVID-19 in large study
· May 1, 2026
Inactivated SARS-CoV-2 vaccine dosing schedules and antibody responses in adults aged 60 to 80 years Older adults get better protection with the right vaccine booster timing
Frontiers · Apr 30, 2026
Survey finds physicians show stronger intergroup bias than public on vaccines Doctors Show Strong Bias Against Vaccine-Hesitant Patients
medRxiv · Apr 26, 2026
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial Metformin Cuts Long Covid Risk by 40%
CT.gov · Apr 24, 2026